Chairperson(s) : Sung Nim Han (Seoul National University, Republic of Korea), Myoung Sook Lee (Sungshin Women's University, Republic of Korea)
Panel(s) : Hyunju Kang (Kyungpook National University, Republic of Korea), Jun Namkung (Yonsei University, Republic of Korea), Chan Joo Lee (Yonsei University, Republic of Korea)
-
Gut microbiota remodeling in infection and inflammation
Eun-Kyeong Jo Chungnam National University, Republic of Korea 13:00~14:30 -
Ketogenic adaptation to intermittent fasting: implications for nutritional immunometabolism
Kyoung-Han Kim University of Ottawa, Canada 13:20~13:40 -
Spatiotemporal immune activation drives metabolic quiescence in brown adipose tissue
Su Myung Jung Sungkyunkwan University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
Chairperson(s) : Chi Dae Kim (Pusan National University, Republic of Korea), Young-Guen Kwon (Young-Guen Kwon, Republic of Korea)
Panel(s) : Yongseek Park (Kyung Hee University, Republic of Korea), Jun Hwan Cho (Chung-Ang University, Republic of Korea), Jae-Hoon Choi (Hanyang University, Republic of Korea)
-
Biobank resources for human metabolic and vascular research
Hyun Joung Lim National Institute of Health, Republic of Korea 13:00~13:20 -
Leveraging biobank platforms to study cardiometabolic physiology and disease
Heiko Bugger Medical University of Graz, Austria 13:20~13:40 -
Integrative analysis of metabolic dysfunction
Young Yang Sookmyung Women\'s University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
Chairperson(s) : Young Joon Hong (Chonnam National University, Republic of Korea), Weon Kim (Kyung Hee University, Republic of Korea)
Panel(s) : Ung Kim (Yeungnam University, Republic of Korea), Chang-Hoon Woo (Yeungnam University, Republic of Korea), Jong-Chan Youn (The Catholic University of Korea, Republic of Korea)
-
LDL versus inflammation: what remains after aggressive lipid lowering?
Osung Kwon The Catholic University of Korea, Republic of Korea 13:00~13:18 -
Emerging anti-inflammatory therapies in ASCVD: canakinumab, NLRP3 inhibitors, and beyond
Sung-A Bae Yonsei University, Republic of Korea 13:18~13:36 -
Colchicine for secondary prevention in ASCVD
Dae Young Cheon Hallym University, Republic of Korea 13:36~13:54 -
Immune mechanisms of residual cardiovascular risk: from oxidation-specific epitopes to therapeutic targets
Christoph J. Binder Medical University of Vienna, Austria 13:54~14:12 - Panel Discussion 14:12~14:30
Chairperson(s) : In-Kyung Jeong (Kyung Hee University, Republic of Korea), Hyun Kang (Chung-Ang University, Republic of Korea)
-
Arterial tissue gene expression associated with telomere length attrition in coronary artery disease
Rajkumar Dorajoo Genome Institute of Singapore, Singapore 13:00~13:15 -
Administration of sodium-glucose cotransporter-2 inhibitors following acute myocardial infarction: a systematic review, meta-analysis, and meta-regression of randomized trials
Timotius Ivan Hariyanto Pelita Harapan University, Indonesia 13:15~13:30 -
Sex differences in the diagnosis and treatment for Japanese patients with familial hypercholesterolemia: a retrospective cohort study
Hayato Tada Kanazawa University, Japan 13:30~13:45 -
Tigloylgomisin P inhibits endothelial inflammation by regulating the NF-κB and Smad1/5/9 pathways
Sanguk Yun Inje University, Republic of Korea 13:45~14:00
Chairperson(s) : Hyun Kook (Chonnam National University, Republic of Korea), Jong-Chan Youn (The Catholic University of Korea, Republic of Korea)
-
[OP1-1] Improved survival and in vivo cholesterol-lowering efficacy of microencapsulated Lactobacillus plantarum LAB12
Ismail M. Fareez Universiti Teknologi MARA, Malaysia 14:30~14:40 -
[OP1-2] Lipid accumulation product and visceral adiposity indices as markers of hyperuricemia and gout: a meta-analysis of 575,000 patients
Khalid Sarhan Mansoura University Hospitals, Egypt 14:40~14:50 -
[OP1-3] Distinct vascular targets of metabolic and kidney dysfunction in adults without advanced
Hyo-In Choi Kangbuk Samsung Hospital, Republic of Korea 14:50~15:00 -
[OP1-4] A randomized, double-blind, placebo-controlled, crossover trial to comparatively evaluate the effects of magnesium hydride (MgH2) on endothelial function: a pilot study
Yasuhiro Endo Niigata University of Pharmacy and Medical and Life Sciences, Japan 15:00~15:10 -
[OP1-5] Association of dietary sodium-to-potassium ratio with triglyceride-glucose index and metabolic syndrome risk in Korean adults: using data from the 2022-2023 Korea National Health and Nutrition Examination Survey
Jisu Lee Seoul Women's University, Republic of Korea 15:10~15:20 -
[OP1-6] A newly developed grain-based cereal product for glycemic spike management: effects on glycemic index, glycemic load, and postprandial glucose responses
Soyeon Park Graduate School of Dong-A University, Republic of Korea 15:20~15:30 -
[OP1-7] Nutraceutical modulation of the oral-vascular axis: emerging therapeutic strategies for periodontitis-associated atherosclerosis
Viza Atiq Umar Universitas Islam Sultan Agung, Indonesia 15:30~15:40
Chairperson(s) : Hayato Tada (Kanazawa University, Japan), Sang-Hak Lee (Yonsei University, Republic of Korea)
Panel(s) : Sung Hee Choi (Seoul National University, Republic of Korea)
-
Refined risk assessment in FH
Sayaka Funabashi Kyorin University, Japan 14:30~14:48 - Q&A 14:48~14:52
-
Cause of death in FH
Chan Joo Lee Yonsei University, Republic of Korea 14:52~15:10 - Q&A 15:10~15:14
-
Experience on new drugs for FH: including lomitapide & evinacumab
Hayato Tada Kanazawa University, Japan 15:14~15:32 - Q&A 15:32~15:36
-
Genome editing for precision medicine
HyongBum Kim Yonsei University, Republic of Korea 15:36~15:54 - Q&A 15:54~15:58
Chairperson(s) : Ade Meidian Ambari (University of Indonesia, Indonesia), Ick Mo Chung (Ewha Womans University, Republic of Korea)
Panel(s) : Berlian Idriansyah Idris (EMC Alam Sutera Hospital, Indonesia), Kyung An Kim (The Catholic University of Korea, Republic of Korea), Hyeonju Jeong (Hanyang University, Republic of Korea), Hun Jee Choe (Hallym University, Republic of Korea)
-
The race to the bottom: intensive LDL-C lowering in very high-risk Asian patients
Ade Meidian Ambari University of Indonesia, Indonesia 14:30~14:50 -
Combination therapy in high-risk patients: early vs stepwise approach
Han Na Jung Hallym University, Republic of Korea 14:50~15:10 -
Practical approaches to statin intolerance: from clinical trials to real-world solutions
Jung-Joon Cha Korea University, Republic of Korea 15:10~15:30 - Panel Discussion 15:30~16:00
Chairperson(s) : Geun Sik Hong (Inje University, Republic of Korea), Kwang-Yeol Park (Chung-Ang University, Republic of Korea)
Panel(s) : Bum Joon Kim (University of Ulsan, Republic of Korea), Chi Kyung Kim (Korea University, Republic of Korea), Se-eun Park (Sungkyunkwan University, Republic of Korea)
-
GLP1 RA for stroke prevention
Kang-Ho Choi Chonnam National University, Republic of Korea 14:30~14:50 -
SGLT2 inhibitor for stroke survivors
Jeong-Min Kim Seoul National University, Republic of Korea 14:50~15:10 -
GLP-1 receptor agonists in Alzheimer’s disease
Sang-Won Han Soonchunhyang University, Republic of Korea 15:10~15:30 - Panel Discussion 15:30~16:00
Chairperson(s) : Youngkeun Ahn (Chonnam National University, Republic of Korea), Min Kyong Moon (Seoul National University, Republic of Korea)
Panel(s) : Young Soo Lee (Daegu Catholic University, Republic of Korea), Jun Hwan Cho (Chung-Ang University, Republic of Korea), Sangmo Hong (Hanyang University, Republic of Korea)
-
Choosing the right combination therapy: statin, ezetimibe, PCSK9 inhibitor, or beyond?
Kyung Hoon Cho Chonnam National University, Republic of Korea 16:10~16:28 -
Korean Fact Sheet: Current status of LDL-C control from general population to high-risk groups
Ye Seul Yang Seoul National University, Republic of Korea 16:28~16:46 -
Korean Fact Sheet: Real-world utilization of lipid-lowering agents
Kyuho Kim The Catholic University of Korea, Republic of Korea 16:46~17:04 -
Why are LDL-C targets still unmet? common errors and practical solutions in the clinic
Sang Yeub Lee Chung-Ang University, Republic of Korea 17:04~17:22 - Panel Discussion 17:22~17:40
Chairperson(s) : Sung Rae Kim (The Catholic University of Korea, Republic of Korea), Jae Hyoung Park (Korea University, Republic of Korea)
Panel(s) : Osung Kwon (The Catholic University of Korea, Republic of Korea), Gyu Chul Oh (The Catholic University of Korea, Republic of Korea), Dae Young Cheon (Hallym University, Republic of Korea)
-
Do East Asians need lower statin intensity? ethnic differences in LDL-C response and safety
Eun Jeong Cho Chung-Ang University, Republic of Korea 16:10~16:28 -
Why TG is important in Asians?
Daisaku Masuda Rinku General Medical Center, Japan 16:28~16:46 -
Genetic stratification and treatment response in Korean severe hypertriglyceridemia: a prospective multicenter registry study
Hun Jee Choe Hallym University, Republic of Korea 16:46~17:04 -
Chylomicronemia: past, present and future
Hiroaki Okazaki Teikyo University, Japan 17:04~17:22 - Panel Discussion 17:22~17:40
Chairperson(s) : Eun Gyoung Hong (Hallym University, Republic of Korea), Chul Sik Kim (Yonsei University, Republic of Korea)
Panel(s) : Shinae Kang (Yonsei University, Republic of Korea), JiHyun Ahn (Korea Medical Institute, Republic of Korea), Jung-Joon Cha (Korea University, Republic of Korea)
-
Sex differences in lymphatic function and atherosclerosis outcomes
Catherine Martel University of Montreal, Canada 16:10~16:30 -
Tirzepatide and cardiometabolic outcomes: implications of dual GLP-1/GIP agonism
Yun Kyung Cho University of Ulsan, Republic of Korea 16:30~16:50 -
Effects of SGLT2 inhibitors on lipid metabolism: mechanisms and clinical implications
Jun Hwa Hong Eulji University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
Chairperson(s) : Bum Soon Choi (The Catholic University of Korea, Republic of Korea), Sang-Hyun Kim (Seoul National University, Republic of Korea)
Panel(s) : Ji Won Ryu (Seoul National University, Republic of Korea), Eun Hui Bae (Chonnam National University, Republic of Korea)
-
Lipid abnormalities in CKD
Hong Sang Choi Chonnam National University, Republic of Korea 16:10~16:30 -
Why patients with CKD develop accelerated atherosclerosis
Cheol Ho Park Yonsei University, Republic of Korea 16:30~16:50 -
Cardiovascular prevention in CKD: an endocrinologist’s perspective
Eun Roh Seoul National University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
